MyFinsight
Home
Blog
About
Contact
vrca: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$3,586K
Inventory
$2,304K
Deferred r&d services,
current portion (note...
$1,959K
Collaboration receivable,
billed and unbilled
$282K
Accounts receivable
$7,047K
Cash and cash
equivalents
$21,097K
Other non-current
assets
$376K
Deferred r&d services,
non-current portion (note...
$2,354K
Finance lease
right-of-use asset
$1,050K
Operating lease
right-of-use asset
$616K
Property and equipment,
net
$225K
Total current assets
$36,275K
Total assets
$40,896K
Accumulated deficit
-$316,839K
Total liabilities and
stockholders deficit
$40,896K
Total stockholders
deficit
-$17,040K
Additional paid-in capital
$299,798K
Common stock, 0.0001
par value...
$1K
Total liabilities
$57,936K
Long term debt
$21,619K
R&d funding
liability (note 11)
$4,688K
Derivative liability
$1,762K
Finance lease liability
$629K
Operating lease liability
$330K
Total current
liabilities
$28,908K
Finance lease liability
$366K
Operating lease liability
$335K
Current portion of
long-term debt
$12,458K
Deferred revenue
$1,564K
Accrued expenses and
other current...
$12,600K
Accounts payable
$1,585K
Back
Back
Balance Sheet
source: myfinsight.com
Verrica Pharmaceuticals Inc. (VRCA)
Verrica Pharmaceuticals Inc. (VRCA)